Recombinant Sheep Interleukin-2 receptor subunit alpha (IL2RA)

What is the molecular structure of Recombinant Sheep Interleukin-2 Receptor Subunit Alpha (IL2RA)?

Recombinant Sheep Interleukin-2 Receptor Subunit Alpha (IL2RA) is a full-length mature protein spanning amino acids 22-275 of the native sequence (P26898). The complete amino acid sequence is: EACHDDPPSLRNAMFKVLRYEVGTMINCDCKAGFRRVSAVMRCVGDSSHSAWNNRCFCNSTSPAKNPVKPVTPGSEEQRERKPTDAQSQTQPPEQADLPGHCEEPPPWEHEREPLKRVYHFTLGQTVHYQCAQGFRALHTGPAESTCTMIHGEMRWTRPRLKCISEGANSQAPDEAEPPESTEAPPGSGTFLTTRMAGTTDFQKPTDVVATLDTFIFTTEYQIAVAGCILLLSSILLLSCLTWQRRWKKNRRTI .

The recombinant protein is typically expressed with an N-terminal His tag in E. coli expression systems, which facilitates purification and detection while maintaining functional properties similar to the native protein .

What are the optimal storage and reconstitution conditions for Recombinant Sheep IL2RA?

For optimal stability and activity retention of Recombinant Sheep IL2RA, adhere to the following storage and reconstitution protocols:

Storage Conditions:

• Store lyophilized protein at -20°C/-80°C upon receipt

• Aliquoting is necessary for multiple use scenarios

• Avoid repeated freeze-thaw cycles as they compromise protein integrity

• Working aliquots can be stored at 4°C for up to one week

Reconstitution Protocol:

• Briefly centrifuge the vial prior to opening to bring contents to the bottom

• Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (50% is recommended as standard)

• Create small aliquots for long-term storage at -20°C/-80°C

The reconstituted protein is typically stored in Tris/PBS-based buffer containing 6% Trehalose at pH 8.0, which helps maintain stability during storage and subsequent applications .

What applications is Recombinant Sheep IL2RA suitable for in basic research?

• Binding Assays: To study ligand-receptor interactions with IL-2 and related cytokines

• Cell Signaling Studies: To investigate downstream pathways activated by IL-2/IL2RA interactions

• Comparative Immunology: To examine species-specific differences in IL-2 signaling

• Structural Biology: As a reagent for crystallization and structure determination studies

• Immunoprecipitation: To pull down binding partners and signaling complexes

When designing experiments, researchers should consider that while the protein structure is highly conserved across species, there may be species-specific interaction differences that could affect experimental outcomes, particularly in cross-species applications.

How does Recombinant Sheep IL2RA differ functionally from human and mouse orthologs in experimental systems?

Functional differences between Recombinant Sheep IL2RA and its human and mouse orthologs are important considerations for experimental design, particularly in cross-species studies:

• Binding Affinity: Sheep IL2RA likely exhibits different binding kinetics toward IL-2 compared to human and mouse orthologs

• Signaling Threshold: The activation threshold may differ, affecting downstream pathway sensitivity

• Complex Formation: The stability of the IL-2/IL2R complex could vary between species

Experimental Implications:
When using sheep IL2RA in research models, consider:

• Potential cross-reactivity limitations with human or mouse IL-2

• Different optimal concentrations may be required for activation

• Signaling kinetics likely differ, necessitating species-specific time course studies

These differences underscore the importance of species-matched experimental systems whenever possible, or appropriate validation when using cross-species approaches.

What are the cardiopulmonary effects observed with recombinant IL-2 administration in sheep models, and how might this inform experimental design?

Studies using sheep models have revealed significant cardiopulmonary effects following recombinant IL-2 administration, providing valuable insights for experimental design considerations:

Observed Physiological Changes:
During a 72-hour continuous intravenous infusion of recombinant IL-2 at doses of 5×10^5 U/kg (group 3) or 9×10^5 U/kg (group 4), researchers documented the following dose-dependent effects:

Histological evaluation revealed dose-dependent infiltration of esterase-negative lymphoblastoid cells into lung tissue .

Implications for Experimental Design:

• Dosing Considerations: Lower doses may be preferable to minimize cardiopulmonary complications

• Duration Limitations: Shorter infusion periods might reduce adverse effects

• Monitoring Requirements: Experiments should include cardiopulmonary parameter monitoring

• Control Groups: Studies should incorporate appropriate excipient controls (as in groups 1 and 2)

• Tissue Analysis: Include histological evaluation and lymph flow measurements for comprehensive assessment

These findings highlight the importance of careful physiological monitoring in IL-2-based experimental protocols, and suggest that the "third-space" syndrome observed in human patients also occurs in sheep models .

What methodological approaches are recommended for optimizing the expression and purification of functionally active Recombinant Sheep IL2RA?

Optimizing expression and purification of functionally active Recombinant Sheep IL2RA requires careful attention to several methodological factors:

Expression System Optimization:

• E. coli Expression: While E. coli is commonly used for IL2RA expression , consider:

  • Codon optimization for sheep-specific sequence

  • Low-temperature induction (16-18°C) to enhance proper folding

  • Co-expression with chaperones (e.g., GroEL/GroES) to improve solubility

• Alternative Expression Systems:

  • Mammalian cells (e.g., CHO or HEK293) for proper glycosylation

  • Insect cells (Sf9, Hi5) using baculovirus expression systems

  • Yeast (Pichia pastoris) for secreted expression

Purification Strategy:
For His-tagged Recombinant Sheep IL2RA , a multi-step purification protocol is recommended:

• Initial Capture: Immobilized metal affinity chromatography (IMAC)

  • Use Ni-NTA or Co²⁺ resins with imidazole gradient elution

  • Include reducing agents (1-5 mM β-mercaptoethanol) to prevent disulfide aggregation

• Secondary Purification:

  • Size exclusion chromatography to remove aggregates

  • Ion exchange chromatography for charge variant separation

• Functional Validation:

  • Surface plasmon resonance (SPR) binding assays with IL-2

  • Cell-based reporter assays to confirm biological activity

Quality Control Metrics:

• Purity: >90% by SDS-PAGE and SE-HPLC

• Endotoxin: <1.0 EU/μg protein for in vivo applications

• Aggregation: <5% as measured by dynamic light scattering

• Functional activity: EC₅₀ determination using appropriate bioassays

These methodological approaches can significantly improve the yield and functional quality of Recombinant Sheep IL2RA for research applications.

How can Recombinant Sheep IL2RA be used to study species-specific immunological differences in the IL-2 signaling pathway?

Recombinant Sheep IL2RA offers a valuable tool for comparative immunology studies examining species-specific differences in IL-2 signaling:

Experimental Approaches:

• Comparative Binding Studies:

  • Surface plasmon resonance (SPR) to measure binding kinetics between sheep IL2RA and IL-2 from different species

  • Analysis of heterodimerization with IL-2Rβ and γc chains across species

  • Competition assays with soluble IL2RA and membrane-bound receptors

• Signaling Pathway Analysis:

  • Western blotting for phosphorylated STAT5 activation patterns

  • Temporal dynamics of JAK1/3 phosphorylation

  • Transcriptomic profiling of downstream gene expression changes

• Functional Responses in Mixed Species Systems:

  • Cross-species T cell proliferation assays

  • Cytokine production profiles following IL-2 stimulation

  • NK cell activation studies with recombinant components

Research Applications:

• Evolutionary Immunology: The use of sheep IL2RA in comparative studies can reveal evolutionary adaptations in cytokine signaling networks. Unlike approaches using only human or mouse systems, incorporating sheep components allows triangulation of conserved versus species-specific elements.

• Agricultural Immunology: Understanding sheep-specific IL-2 signaling has direct applications for livestock health, including:

  • Development of species-specific immune modulators

  • Improved vaccine adjuvant design

  • Diagnostic tools for sheep-specific immune disorders

• Biomedical Translation: Species-specific differences identified using sheep IL2RA can inform:

  • Limitations of animal models for human immunotherapy development

  • Novel therapeutic targets based on conserved signaling nodes

  • Safety prediction for cross-species applications of immunomodulatory drugs

By systematically comparing the structure-function relationships between sheep, human, and mouse IL-2 receptor components, researchers can gain insights into both fundamental immunological principles and species-specific adaptations.

What control conditions should be included when testing Recombinant Sheep IL2RA in functional assays?

Robust experimental design for testing Recombinant Sheep IL2RA requires comprehensive controls to ensure valid interpretation of results:

Essential Controls:

• Vehicle Controls:

  • Buffer-only conditions matching the reconstitution buffer (Tris/PBS with 6% Trehalose, pH 8.0)

  • Matched glycerol concentrations when applicable

  • 0.9% NaCl and excipient controls as demonstrated in cardiopulmonary studies

• Protein Controls:

  • Denatured Sheep IL2RA (heat-treated at 95°C for 30 minutes)

  • Non-relevant His-tagged protein expressed in the same system

  • Species-matched control proteins (other sheep cytokine receptors)

• Species Comparison Controls:

  • Parallel testing with human and mouse IL2RA when available

  • Dose-response curves with species-matched IL-2

• Biological System Controls:

  • Cell lines lacking IL-2 receptor components

  • Cells pre-treated with IL-2 pathway inhibitors (JAK inhibitors)

  • Antibody blocking of receptor subunits

Validation Controls:

For signaling studies, include positive controls such as:

• Recombinant IL-2 at established effective concentrations

• Pan-STAT activators (e.g., pervanadate)

• Receptor-independent pathway activators

This comprehensive control strategy allows researchers to distinguish specific IL2RA-mediated effects from non-specific protein effects, expression system artifacts, and general experimental variables.

How can researchers assess the stability and functionality of Recombinant Sheep IL2RA after various storage and handling conditions?

Systematic assessment of Recombinant Sheep IL2RA stability and functionality is critical for experimental reproducibility:

Stability Assessment Protocol:

• Physical Stability Measurements:

  • SDS-PAGE analysis (reducing and non-reducing) after storage intervals

  • Size exclusion chromatography to monitor aggregation

  • Dynamic light scattering for particle size distribution

  • Circular dichroism to monitor secondary structure changes

• Thermal Stability Testing:

  • Differential scanning fluorimetry (DSF) to determine melting temperature

  • Accelerated stability studies at elevated temperatures (37°C, 45°C)

  • Freeze-thaw cycle testing (up to 5 cycles)

  • Heat challenge testing similar to that performed with Neo-2/15

• Storage Condition Comparison:

  Storage Condition	Testing Intervals	Analysis Methods
  -80°C (reference)	0, 1, 3, 6, 12 months	SDS-PAGE, Bioactivity
  -20°C	0, 1, 3, 6, 12 months	SDS-PAGE, Bioactivity
  4°C	0, 1, 2, 4 weeks	SDS-PAGE, Bioactivity
  Room temperature	0, 1, 3, 7 days	SDS-PAGE, Bioactivity
  After reconstitution	0, 1, 3, 7 days at 4°C	SDS-PAGE, Bioactivity

Functionality Assessment:

• Binding Activity:

  • ELISA-based binding assays with recombinant IL-2

  • Surface plasmon resonance for binding kinetics after storage

  • Flow cytometry with fluorescently labeled protein

• Biological Activity:

  • T cell proliferation assays

  • STAT5 phosphorylation in responsive cell lines

  • Comparative EC₅₀ determination before and after storage

This systematic approach allows researchers to establish evidence-based handling guidelines beyond the standard recommendations , and may identify unexpected stability characteristics similar to the exceptional thermal stability observed in designer cytokines like Neo-2/15, which maintained activity after 2 hours at 80°C .

What methodologies can be used to investigate the interactions between Recombinant Sheep IL2RA and its signaling partners?

Investigating the interactions between Recombinant Sheep IL2RA and its signaling partners requires sophisticated methodological approaches spanning structural biology, protein biochemistry, and cellular immunology:

Structural Interaction Studies:

• Co-crystallization:

  • Complex formation between purified sheep IL2RA and IL-2

  • X-ray crystallography to determine binding interfaces

  • Comparison with established human IL-2/IL2R complex structures

• Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Mapping conformational changes upon binding

  • Identification of flexible regions and binding interfaces

  • Comparison of solution-phase dynamics with crystal structures

• Cryo-Electron Microscopy:

  • Visualization of the complete IL-2R complex with all subunits

  • Analysis of conformational heterogeneity

  • Comparison with the established four-helix bundle structure of IL-2

Biochemical Interaction Analysis:

• Surface Plasmon Resonance (SPR):

  • Determination of kon and koff rates

  • Calculation of binding affinity (KD)

  • Competition assays with other receptor subunits

• Isothermal Titration Calorimetry (ITC):

  • Thermodynamic profiling of binding interactions

  • Enthalpy and entropy contributions to binding

  • Stoichiometry determination

• Bio-Layer Interferometry:

  • Real-time binding analysis

  • High-throughput screening of binding conditions

  • Determination of binding kinetics

Cellular Signaling Analysis:

• Proximity Ligation Assays:

  • Visualization of receptor subunit interactions

  • Quantification of complex formation in situ

  • Temporal dynamics of receptor assembly

• CRISPR-Edited Reporter Systems:

  • Endogenous tagging of signaling components

  • Live-cell imaging of signaling events

  • Quantitative analysis of signal transduction

• Phospho-Specific Flow Cytometry:

  • Single-cell analysis of pathway activation

  • Kinetic studies of signaling events

  • Heterogeneity assessment in mixed cell populations

These methodologies, when applied systematically, can provide comprehensive insights into how sheep IL2RA participates in the formation of functional signaling complexes, potentially revealing species-specific interaction patterns compared to the extensively studied human IL-2 receptor system .

What are common challenges when working with Recombinant Sheep IL2RA, and how can researchers address them?

When working with Recombinant Sheep IL2RA, researchers frequently encounter several technical challenges that require specific troubleshooting approaches:

Challenge 1: Protein Aggregation

• Symptoms: Visible precipitates after reconstitution, shifted peaks in size exclusion chromatography, or reduced activity

• Solutions:

  • Reconstitute in buffer containing 0.1% BSA as carrier protein

  • Use gentle mixing rather than vortexing during reconstitution

  • Centrifuge reconstituted protein (10,000 × g, 10 min) to remove aggregates

  • Add non-ionic detergents (0.01% Tween-20) to storage buffer

Challenge 2: Loss of Activity During Storage

• Symptoms: Reduced binding or functional response in bioassays

• Solutions:

  • Store in small single-use aliquots to avoid freeze-thaw cycles

  • Add stabilizing agents such as trehalose (present in the recommended buffer)

  • Store concentrated stocks (>0.5 mg/mL) when possible

  • Consider flash-freezing aliquots in liquid nitrogen before -80°C storage

Challenge 3: Non-specific Binding in Assays

• Symptoms: High background in binding assays, unexpected cellular responses

• Solutions:

  • Include blocking agents (1-5% BSA or gelatin) in assay buffers

  • Pre-clear solutions by centrifugation before assays

  • Include competing non-relevant proteins in binding assays

  • Validate specificity with blocking antibodies against IL2RA

Challenge 4: Species Cross-Reactivity Issues

• Symptoms: Inconsistent results when using sheep IL2RA with human or mouse cells/proteins

• Solutions:

  • Design species-matched experimental systems when possible

  • Determine cross-reactivity empirically before complex experiments

  • Consider domain-swapping approaches for mechanistic studies

  • Use computational modeling to predict cross-species compatibility

Addressing these challenges through systematic optimization can significantly improve experimental outcomes when working with Recombinant Sheep IL2RA.

How can the functional activity of Recombinant Sheep IL2RA be quantitatively assessed in research applications?

Quantitative assessment of Recombinant Sheep IL2RA functional activity requires multi-parameter approaches to ensure comprehensive characterization:

Biochemical Activity Assays:

• Binding Affinity Determination:

  • Surface plasmon resonance (SPR) to determine KD values

  • Bio-layer interferometry for real-time binding kinetics

  • Fluorescence polarization assays with labeled IL-2

• Thermal Shift Assays:

  • Differential scanning fluorimetry to assess stability

  • Correlate Tm values with functional activity

  • Compare with known active/inactive reference standards

Cellular Functional Assays:

• Signaling Pathway Activation:

  • Quantitative phospho-flow cytometry for STAT5 phosphorylation

  • Western blot densitometry for JAK/STAT activation

  • Dose-response curves with calculated EC₅₀ values

• Transcriptional Response:

  • RT-qPCR for IL-2-responsive genes

  • RNA-seq for global transcriptional changes

  • Luciferase reporter assays for specific pathway activation

• Proliferation and Survival:

  • MTT/XTT proliferation assays with IL-2-dependent cell lines

  • BrdU incorporation to measure cell division

  • Flow cytometry with viability dyes for survival assessment

Standardization Approaches:

To enable quantitative comparisons between different batches or experimental conditions, establish:

• Reference Standards:

  • Validated standard curves with known activity units

  • Internal reference controls in each assay

  • Positive control with established potency (e.g., recombinant IL-2)

• Activity Units Calculation:

  Activity Type	Calculation Method	Units
  Binding Activity	EC₅₀ in competitive binding assay	nM
  Signaling Potency	EC₅₀ for pSTAT5 induction	pM or nM
  Biological Potency	Relative to reference standard	IU/mg
  Specific Activity	Bioactivity/protein concentration	IU/μg

By implementing these quantitative assessment methods, researchers can reliably compare results across experiments and ensure consistent functional activity of Recombinant Sheep IL2RA preparations.

How might insights from de novo designed IL-2 mimetics inform the development of engineered sheep IL2RA variants with enhanced research applications?

Recent advances in de novo protein design, particularly the development of IL-2 mimetics, provide valuable frameworks for engineering enhanced sheep IL2RA variants for research:

Lessons from De Novo IL-2 Mimetics:

The development of Neo-2/15, a hyperstable IL-2 mimetic that selectively binds IL-2Rβγc without IL-2Rα interaction , offers several design principles:

• Structural Optimization:

  • Idealized secondary structure elements improve stability

  • Parametric variation of helix lengths enables exploration of optimal configurations

  • Fragment-derived loops provide reliable connections between structural elements

• Interface Engineering:

  • Selective receptor subunit targeting through precise interface design

  • Elimination of unwanted interactions by structural reorganization

  • Enhanced affinity through computational design and experimental optimization

Potential Engineered Sheep IL2RA Variants:

• Stability-Enhanced Variants:

  • Introduction of disulfide bonds at computationally identified positions

  • Helix stabilization through strategic salt bridge placement

  • Core repacking for improved thermostability similar to Neo-2/15

• Specificity-Modified Variants:

  • Engineered variants with altered binding specificity for different IL-2 orthologs

  • Selective binding to specific receptor subunit combinations

  • Species-crossing variants with broader research applications

• Functional Reporter Variants:

  • Integration of fluorescent sensors to report binding events

  • Conformational change-responsive elements

  • Split protein complementation systems for interaction studies

Methodological Approach:

A combined computational-experimental pipeline similar to that used for Neo-2/15 would involve:

• Computational design of idealized sheep IL2RA variants

• Yeast display screening for binding and stability

• Site-saturation mutagenesis of promising candidates

• Combinatorial libraries for affinity maturation

• Recombinant expression and biophysical characterization

• Functional validation in cellular assays

This approach could yield sheep IL2RA variants with unprecedented stability, specificity, and research utility, potentially enabling new experimental paradigms in comparative immunology and receptor biology.

What implications do the cardiopulmonary effects of IL-2 in sheep models have for translational research and therapeutic development?

The documented cardiopulmonary effects of IL-2 in sheep models have significant implications for translational research and therapeutic development:

Translational Insights from Sheep Models:

The chronic sheep model study revealed several important physiological responses to recombinant IL-2 administration:

• Vascular Effects:

  • Dose-dependent decrease in systemic blood pressure

  • Increased pulmonary arterial pressure (from 13±5 to 21±6 mmHg)

  • These changes suggest complex vascular regulation during IL-2 therapy

• Pulmonary Complications:

  • Decreased arterial PO₂

  • Increased lung lymph flow

  • Elevated extravascular lung water-to-dry lung weight ratio

  • Infiltration of lymphoblastoid cells into lung tissue

• Systemic Responses:

  • Increased core temperature

  • Development of "third-space" syndrome

Implications for Therapeutic Development:

• Safety Monitoring Requirements:

  • Cardiopulmonary parameters should be closely monitored in clinical applications

  • Dose-finding studies should include comprehensive cardiovascular assessment

  • Pre-existing pulmonary or cardiovascular conditions may represent contraindications

• Formulation and Delivery Strategies:

  • Targeted delivery systems might reduce systemic exposure and cardiopulmonary effects

  • Pulsed dosing protocols could allow recovery periods between treatments

  • Combined therapy with cardioprotective or vasopressor agents might mitigate adverse effects

• Engineering Improved Variants:

  • Development of IL-2 variants with reduced vascular leak syndrome potential

  • Selective targeting of beneficial receptor subunits (similar to the approach of Neo-2/15)

  • Modifications to reduce cytokine storm potential while maintaining therapeutic efficacy

• Predictive Biomarkers:

  • Identification of early biomarkers for cardiopulmonary complications

  • Development of patient stratification criteria to identify those at higher risk

  • Monitoring protocols specifically designed for IL-2-based therapies

These implications highlight how detailed understanding of species-specific responses to IL-2 can inform safer and more effective therapeutic strategies, potentially leading to improved clinical outcomes in human patients.

What emerging technologies might enhance our understanding of Recombinant Sheep IL2RA structure-function relationships?

Several cutting-edge technologies are poised to advance our understanding of Recombinant Sheep IL2RA structure-function relationships:

Advanced Structural Biology Approaches:

• AlphaFold and Related AI Methods:

  • Prediction of sheep IL2RA structures with unprecedented accuracy

  • Modeling of complex formation with binding partners

  • Identification of critical interaction residues for functional studies

• Single-Particle Cryo-EM:

  • Visualization of complete receptor complexes in near-native states

  • Conformational dynamics of receptor-ligand interactions

  • Structural changes associated with signal transduction

• Integrative Structural Biology:

  • Combining multiple experimental approaches (crystallography, HDX-MS, SAXS)

  • Computational integration of diverse structural data

  • Construction of dynamic models of receptor complexes

Functional Genomics and Systems Biology:

• CRISPR-Based Functional Screens:

  • Systematic analysis of genes affecting IL2RA function

  • Identification of species-specific regulatory elements

  • Engineering of optimized cellular systems for IL2RA research

• Single-Cell Multi-Omics:

  • Correlation of receptor expression with transcriptional responses

  • Identification of cell-specific signaling networks

  • Heterogeneity analysis of IL-2 responses in complex tissues

• Spatial Transcriptomics:

  • Tissue-level analysis of IL-2 signaling in sheep tissues

  • Correlation of receptor distribution with functional outcomes

  • Comparative analysis across different species

These emerging technologies promise to provide unprecedented insights into the basic biology of sheep IL2RA and its potential applications in comparative immunology, veterinary medicine, and translational research.

How can researchers leverage cross-species comparisons of IL2RA to advance fundamental immunological understanding?

Cross-species comparisons of IL2RA offer powerful approaches to address fundamental immunological questions:

Evolutionary Immunology Applications:

• Phylogenetic Analysis:

  • Reconstruction of IL2RA evolution across vertebrate lineages

  • Identification of conserved versus diversified functional domains

  • Correlation of sequence changes with ecological or pathogen pressures

• Structure-Function Conservation:

  • Comparison of binding interfaces across species

  • Identification of invariant residues essential for function

  • Analysis of species-specific adaptations in receptor signaling

• Signaling Network Evolution:

  • Comparative analysis of downstream pathway components

  • Species-specific feedback mechanisms

  • Co-evolution of cytokine-receptor pairs

Translational Research Opportunities:

• One Health Approaches:

  • Understanding IL-2 biology across humans, livestock, and wildlife

  • Development of broad-spectrum immunomodulators

  • Comparative studies of immune-mediated diseases

• Therapeutic Development:

  • Leveraging natural receptor variations to design improved therapeutics

  • Species-optimized IL-2 formulations for veterinary applications

  • Identification of unexplored signaling mechanisms with therapeutic potential

• Model System Validation:

  • Critical assessment of animal models for human IL-2 biology

  • Identification of species-specific limitations in preclinical studies

  • Development of more predictive experimental systems

By systematically comparing IL2RA structure, function, and signaling across species, researchers can uncover both conserved immunological principles and species-specific adaptations, ultimately advancing both basic science and applied therapeutic development.